LEADER 01406nam 2200409 a 450 001 9910703222203321 005 20120125094351.0 035 $a(CKB)4950000000104822 035 $a(OCoLC)765450664 035 $a(EXLCZ)994950000000104822 100 $a20111201d2011 ua 0 101 0 $aeng 135 $aurmn||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aSpending patterns for prescription drugs under Medicare Part D$b[electronic resource] 210 1$a[Washington, D.C.] :$cCongressional Budget Office,$d[2011] 215 $a1 online resource (12 pages) $cillustrations 225 1 $aEconomic and budget issue brief 300 $aTitle from caption, PDF title screen (viewed Dec. 1, 2011). 300 $a"December 2011." 320 $aIncludes bibliographical references. 606 $aMedical fees$zUnited States 606 $aMedicare 606 $aPharmaceutical services insurance$xSubsidies$zUnited States 615 0$aMedical fees 615 0$aMedicare. 615 0$aPharmaceutical services insurance$xSubsidies 700 $aHayford$b Tamara$01403390 712 02$aUnited States.$bCongressional Budget Office. 801 0$bGPO 801 1$bGPO 906 $aBOOK 912 $a9910703222203321 996 $aSpending patterns for prescription drugs under Medicare Part D$93543679 997 $aUNINA